The global cord blood banking services market size was valued at USD 2.29 billion in 2025 and is projected to grow from USD 2.61 billion in 2026 to USD 7.33 billion by 2034, registering a CAGR of 13.8% during the forecast period from 2026 to 2034. North America dominated the cord blood banking services market with a market share of 38.7% in 2025.
Cord blood banking services involve the collection, processing, and long-term storage of stem cell-rich blood from a newborn's umbilical cord for potential future use in treating blood disorders, genetic diseases, immune deficiencies, and certain cancers.
Download a Free Sample To learn more about this report,
Growing Emphasis on Quality, Accreditation, and Standardized Cord Blood Banking
The cord blood banking services market is shifting toward stronger quality-management and accreditation practices across collection, processing, cryopreservation, storage, and release activities. As cord blood units may be used for hematopoietic stem cell transplantation, banks are placing greater emphasis on standardized procedures, traceability, donor screening, and product quality to meet clinical and regulatory requirements.
Increasing Integration of Cord Blood Banking With Advanced Cell Therapy Applications
Cord blood banking is increasingly connected to the broader cellular-therapy ecosystem as cord-derived hematopoietic progenitor cells continue to support transplantation and related therapeutic development. This is encouraging banks to strengthen cell characterization, preservation, and distribution capabilities while improving their ability to supply clinically usable units.
Rising Use of Hematopoietic Stem Cell Transplantation Supports Cord Blood Banking Demand
Cord blood contains hematopoietic progenitor cells that can be used for transplantation in patients with certain blood, immune, and inherited disorders. The clinical use of these cells creates demand for professional collection, processing, testing, cryopreservation, storage, and distribution services provided by cord blood banks.
High Long-Term Storage and Quality-Control Requirements Increase Banking Costs
Cord blood banks must maintain controlled collection, processing, testing, cryopreservation, and long-term storage systems while preserving product integrity. These requirements involve specialized facilities, equipment, monitoring, trained personnel, and regulatory compliance, increasing the cost of maintaining stored units over extended periods.
Expansion of Global Cord Blood Networks Creates Opportunities for Broader Unit Access
Greater integration between cord blood banks, donor registries, and transplant centers can expand access to stored units across national borders. Standardized data, certification, and distribution processes allow banks to make cord blood inventories available to a broader transplant population, creating opportunities for services supporting international search, matching, allocation, and distribution.
Maintaining Consistent Cell Quality Across Collection and Long-Term Storage Remains Difficult
Cord blood units must retain sufficient cellular quality and viability from collection through processing, cryopreservation, storage, transport, and eventual transplantation. Variations in collection conditions, processing procedures, storage controls, and release criteria can affect the suitability of units, requiring stringent quality systems throughout the banking lifecycle.
The service segment accounted for the largest share of the global cord blood banking services market, holding 65.8% in 2025. The segment dominates due to the increasing preference for comprehensive cord blood banking services, including collection, processing, cryopreservation, and long-term storage. Growing awareness among expectant parents, coupled with advancements in stem cell preservation technologies and the expansion of private and public banking facilities, continues to strengthen the demand for these services.
Request Customizationto receive a tailored report.
The cancer segment is expected to register the fastest growth, expanding at a CAGR of 10.42% during the forecast period (2026–2034). The growth is driven by the increasing use of cord blood stem cells in the treatment of hematological malignancies such as leukemia, lymphoma, and multiple myeloma. Ongoing advancements in stem cell transplantation and rising investments in oncology research are further supporting the adoption of cord blood banking services for cancer-related applications.
The cord blood segment held the largest share of the global market, accounting for 72.9% in 2025. The segment's dominance is attributed to the high concentration of hematopoietic stem cells found in cord blood, making it a valuable source for treating blood disorders, immune deficiencies, and inherited metabolic diseases. Increasing clinical applications and continuous progress in regenerative medicine continue to drive the demand for cord blood preservation worldwide.
The analysis segment is projected to witness the fastest growth, registering a CAGR of 10.86% during the forecast period (2026–2034). The growth is supported by the increasing need for quality assessment, infectious disease screening, stem cell viability testing, and genetic analysis before long-term cryopreservation. Growing regulatory requirements and advancements in laboratory diagnostics are encouraging cord blood banks to invest in advanced analytical services, thereby driving segment growth.
Speak to an Analystto discuss market opportunities.
North America dominated the global cord blood banking services market, accounting for 38.7% of the market in 2025, valued at USD 0.89 billion, and is projected to grow at a CAGR of 8.92% during the forecast period. The region's leadership is driven by the presence of well-established public and private cord blood banks, advanced healthcare infrastructure, growing awareness of stem cell preservation, and increasing investments in regenerative medicine. Rising adoption of cell and gene therapies and supportive regulatory frameworks continue to strengthen regional market growth.
The U.S. cord blood banking services market was valued at USD 0.71 billion in 2025. The country dominates the regional market due to its advanced stem cell banking infrastructure, increasing clinical research in regenerative medicine, and growing adoption of cell and gene therapies. Rising awareness among expectant parents and the presence of leading cord blood banking companies continue to drive market expansion.
The Canada cord blood banking services market was valued at USD 0.18 billion in 2025. Growth is supported by expanding stem cell research, increasing public cord blood banking initiatives, and rising awareness of newborn stem cell preservation. Government support for regenerative medicine research and improving healthcare infrastructure are encouraging greater adoption of cord blood banking services.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for 27.4% of the global cord blood banking services market in 2025, reaching USD 0.63 billion, and is expected to grow at a CAGR of 9.31% during the forecast period. Market growth is driven by expanding stem cell transplantation programs, increasing investments in regenerative medicine, supportive regulatory policies, and the presence of established public cord blood banking networks across the region.
The UK cord blood banking services market was valued at USD 0.19 billion in 2025. Rising investments in stem cell research, growing awareness of cord blood preservation, and strong support for public banking programs are supporting market growth. The country's expanding regenerative medicine sector is further increasing demand for cord blood banking services.
The Germany cord blood banking services market was valued at USD 0.25 billion in 2025. Germany's advanced healthcare system, growing stem cell research activities, and increasing adoption of regenerative medicine continue to drive demand for cord blood banking services. The presence of established biobanking facilities further strengthens the country's market position.
Asia Pacific held 22.6% of the global cord blood banking services market in 2025, valued at USD 0.52 billion, and is projected to grow at a CAGR of 12.48% during the forecast period. The region is experiencing rapid growth due to expanding healthcare infrastructure, increasing birth rates, rising awareness of stem cell preservation, and growing investments in regenerative medicine and biotechnology.
The Japan cord blood banking services market was valued at USD 0.16 billion in 2025. Market growth is supported by the country's advanced regenerative medicine ecosystem, increasing stem cell research, and supportive government policies for cell-based therapies. Continuous innovation in stem cell preservation technologies is further boosting demand.
The China cord blood banking services market was valued at USD 0.24 billion in 2025. Rapid expansion of the biotechnology industry, increasing healthcare expenditure, government support for regenerative medicine, and growing adoption of private cord blood banking services continue to drive market growth across the country.
The Middle East & Africa accounted for 4.5% of the global cord blood banking services market in 2025, with a market value of USD 0.10 billion, and is projected to grow at a CAGR of 8.64% during the forecast period. Increasing healthcare investments, improving awareness of stem cell preservation, and the gradual expansion of cord blood banking facilities are contributing to market growth across the region.
The UAE cord blood banking services market was valued at USD 0.04 billion in 2025. The country's expanding private healthcare sector, increasing investments in biotechnology, and government initiatives to strengthen advanced healthcare services are supporting demand for cord blood banking services.
The Africa cord blood banking services market was valued at USD 0.06 billion in 2025. Growth is driven by improving healthcare infrastructure, increasing maternal healthcare services, rising awareness of stem cell preservation, and the gradual expansion of public and private cord blood banking facilities across several African countries.
The global cord blood banking services market is moderately fragmented, with the presence of several international and regional companies offering private and public cord blood banking, stem cell processing, cryopreservation, and long-term storage services. Leading market participants include Cordlife Group Limited, CBR Systems Inc., Cryo-Cell International Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord Inc., Virgin Health Bank, and others.
Industry participants are focusing on expanding storage capacity, strengthening laboratory infrastructure, adopting advanced cryopreservation technologies, and forming strategic partnerships with hospitals and maternity centers. Companies are also investing in digital sample tracking systems and regenerative medicine research to enhance service quality, improve stem cell preservation, and expand their global customer base.
CBR Systems Inc.: A Leading Market Player
CBR Systems Inc. is one of the leading providers of newborn stem cell preservation services, offering cord blood and cord tissue banking for families worldwide. The company focuses on advanced stem cell processing technologies, long-term cryogenic storage, and research collaborations to support the growing adoption of regenerative medicine and personalized healthcare.
For instance, in May 2025, CBR Systems Inc. announced a research collaboration to expand the clinical use of newborn stem cells in regenerative medicine and pediatric therapies. The initiative aims to support ongoing clinical research while strengthening the company's position in the global market.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
India Pharmaceutical Stability and Storage Services Market Size, Share & Trends | Industry Report, 2034
Healthcare Regulatory Affairs Outsourcing Market Size, Share, 2034
Facial Fat Transfer Market Size, Share, Growth, Analysis, 2034
Viral Vector Manufacturing Market Size, Share, Growth, Analysis, 2034
Medical Equipment Rental Market Size, Share, Growth, 2034
Pharmaceutical Stability and Storage Services Market Size, 2034
We are featured on:
sales@straitsresearch.com